CIRCOMAX MYCO ΕΝΕΣΙΜΟ ΓΑΛΑΚΤΩΜΑ

Country: Greece

Language: Greek

Source: Εθνικός Οργανισμός Φαρμάκων

Active ingredient:

INACTIVATED MYCOPLASMA HYOPNEUMONIAE, STRAIN P-5722-3; INACTIVATED RECOMBINANT CHIMERIC PORCINE CIRCOVIRUS TYPE 1 CONTAINING THE PORCINE CIRCOVIRUS TYPE 2B ORF2 PROTEIN; INACTIVATED RECOMBINANT CHIMERIC PORCINE CIRCOVIRUS TYPE 1 CONTAINING THE PORCINE CIRCOVIRUS TYPE 2B ORF2 PROTEIN

Available from:

ZOETIS BELGIUM S.A., LOUVAIN-LA-NEUVE, BELGIUM (0000011199) Rue Laid Burniat 1,1348,Louvain-la-Neuve,BE

ATC code:

QI09AL08

INN (International Name):

INACTIVATED MYCOPLASMA HYOPNEUMONIAE, STRAIN P-5722-3; INACTIVATED RECOMBINANT CHIMERIC PORCINE CIRCOVIRUS TYPE 1 CONTAINING THE PORCINE CIRCOVIRUS TYPE 2B ORF2 PROTEIN; INACTIVATED RECOMBINANT CHIMERIC PORCINE CIRCOVIRUS TYPE 1 CONTAINING THE PORCINE CIRCOVIRUS TYPE 2B ORF2 PROTEIN

Pharmaceutical form:

ΕΝΕΣΙΜΟ ΓΑΛΑΚΤΩΜΑ

Composition:

INACTIVATED MYCOPLASMA HYOPNEUMONIAE, STRAIN P-5722-3 0,00 EM.INJ 0; INACTIVATED RECOMBINANT CHIMERIC PORCINE CIRCOVIRUS TYPE 1 CONTAINING THE PORCINE CIRCOVIRUS TYPE 2B ORF2 PROTEIN 0,00 EM.INJ 0; INACTIVATED RECOMBINANT CHIMERIC PORCINE CIRCOVIRUS TYPE 1 CONTAINING THE PORCINE CIRCOVIRUS TYPE 2B ORF2 PROTEIN 0,00 EM.INJ 0

Administration route:

Ενδομυική χρήση

Class:

ΕΜΒΟΛΙΑ

Prescription type:

Με Ιατρική Συνταγή

Therapeutic group:

Χοίροι

Therapeutic area:

porcine circovirus + mycoplasma

Therapeutic indications:

Χρόνοι αναμονής: Χοίροι 0 Ημέρες Κρέας και εδώδιμοι ιστοί

Product summary:

Συσκευασίες: 2811022101013 BT x 1 HDPE VIAL x 50ML ; 2811022101020 BT x 1 HDPE VIAL x 100ML ; 2811022101037 BT x 1 HDPE VIAL x 250ML ; 2811022101044 BT x 10 HDPE VIALS x 50ML ; 2811022101051 BT x 10 HDPE VIALS x 100ML ; 2811022101068 BT x 4 HDPE VIALS x 250ML

Authorization status:

Έγκυρη